Abstract
Eptinezumab (ALD-403) is a genetically engineered humanized IgG1 kappa directed towards calcitonin generelated peptide (CGRP), currently in late-stage......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
